A stiff patient

Case 21 - A stiff patient

Published online by Cambridge University Press: 19 October 2021

Joshua Valverde and

Edited by

Gerald Maguire and

Takesha Cooper: Affiliation:
University of California, Riverside
Gerald Maguire: Affiliation:
University of California, Riverside
Stephen Stahl: Affiliation:
University of California, San Diego

Book contents

Get access

Summary

Pretest self-assessment question (answer at the end of the case)

Type: Chapter
Information: Case Studies: Stahl's Essential Psychopharmacology , pp. 237 - 250

DOI: https://doi.org/10.1017/9781009026499 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Subscription

Individual access

Subscriptions are only available for individuals and not institutional access. Subscribe now

References

Ahmed, S, Chengappa, KN, Naidu, VR, et al. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998; 59:472–7. https://doi.org/10.4088/jcp.v59n0906 CrossRef Google Scholar PubMed

Bobolakis, I. Neuroleptic malignant syndrome after antipsychotic drug administration during benzodiazepine withdrawal. J Clin Psychopharmacol 2000; 20:281–3. https://doi.org/10.1097/00004714-200004000-00033 Google Scholar

Brown, M, Freeman, S. Clonazepam withdrawal-induced catatonia. Psychosomatics 2009; 50:289–92. https://doi.org/10.1176/appi.psy.50.3.289 Google Scholar

Cummings, M, Stahl, S., Management of Complex Treatment-resistant Psychotic Disorders. New York, NY: Cambridge University Press, 2020.Google Scholar

Galova, A, Berney, P, Desmeules, J, et al. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder. BMC Psychiatry 2019; 19:73. https://doi.org/10.1186/s12888-019-2055-1 Google Scholar

Lee, JW, Robertson, S. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry 1997; 9:165–9. https://doi.org/10.1023/a:1026230024656 Google Scholar

Meyer, J, Stahl, SM. Clozapine Handbook. New York, NY: Cambridge University Press, 2019.CrossRef Google Scholar

Nayak, V, Chogtu, B, Devaramane, V, Bhandary, PV. Pedal edema with olanzepine. Indian J Pharmacol 2009; 41:49–50. https://doi.org/10.4103/0253-7613.48883 Google Scholar

Rosebush, PI, Mazurek, MF. Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 1996; 16:315–19. https://doi.org/10.1097/00004714-199608000-00007 Google Scholar

Stahl, SM. Essential Psychopharmacology: The Prescriber’s Guide. New York, NY: Cambridge University Press, 2005.Google Scholar

Stonecipher, A, Galang, R, Black, J. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome. Gen Hosp Psychiatry 2006; 28:541–3. https://doi.org/10.1016/j.genhosppsych.2006.07.007 CrossRef Google Scholar PubMed

Wadekar, M, Syed, S. Clozapine-withdrawal catatonia. Psychosomatics 2010; 51:355. https://doi.org/10.1176/appi.psy.51.4.355 Google Scholar

Yeh, AWC, Lee, JW, Cheng, TC, et al. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report. Clin Neuropharmacol 2004: 27:216–18. https://doi.org/10.1097/01.wnf.0000145506.99636.1b Google Scholar